用转基因树突细胞治疗自身免疫性疾病的新兴策略
Yunhan Ma1, Ruobing Shi1, Fujun Li2
1School of Medicine, Jiangsu University, Zhenjiang, 212000, China.
Cell communication and signaling : CCS
|May 7, 2024
概括
基因编辑增强了用于细胞疗法的宽容性树突细胞 (TolDCs). 本综述探讨了改善TolDC功能的临床前策略,并克服了各种疾病治疗中更广泛的临床应用的挑战.
科学领域:
- 免疫学和细胞疗法
- 基因编辑技术的技术
- 翻译医学是一种翻译医学.
背景情况:
- 基因编辑在医学研究和细胞治疗中至关重要,有助于推进瘤治疗和管理免疫疾病.
- 宽容性树突细胞 (TolDC) 免疫疗法在临床试验中显示出安全性,但需要提高有效性.
研究的目的:
- 审查基因编辑应用程序以增强树突细胞 (DC) 耐受性功能.
- 专注于临床前策略,优化DCs的宽容性表型和功能.
- 讨论TolDC疗法的挑战和未来方向.
主要方法:
- 探索用于TolDCs的体外生成方法.
- 使用基因编辑修改DC的新兴策略的概述.
- 对当前关于增强DC耐受性的临床前研究进行分析.
主要成果:
- 基因编辑有可能显著提高基于TolDC的疗法的疗效.
- 临床前研究正在研究各种方法来优化DC修改以提高免疫耐受性.
- 确定了一些关键挑战,这些挑战阻碍了TolDC疗法的临床转化.
结论:
- 基因编辑有望通过提高其功能能力来推进TolDC免疫疗法.
- 需要进一步的研究来克服现有的障碍,并促进这些修饰细胞疗法的临床采用.
- 通过基因编辑优化DC表型和功能对于未来的治疗成功至关重要.
更多相关视频
06:09Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
Published on: June 22, 2016
23.1K
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
215
相关概念视频
01:27Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
01:40Cell-mediated Immune Responses
68.2K
Overview
68.2K